Vertex Portfolio News

Here are the latest updates on our portfolio companies across the Vertex network. Stay connected by signing up for our monthly newsletter here.

• Chamlion (CN) raised RMB 236 M in Series B fundraising, building a new eco-system of digital dentistry
• Evolusia (CN) completed USD14.5M round of financing (Article in CN)
• TORL BioTherapeutics (HC) launched with USD 158M Series B round to advance development of novel oncology biologics
• Virta (Growth) raised USD93.8 M to grow its charging transactions by more than 5x in the Asia Pacific and Europe by 2025

• Ace Turtle (SEAI & Growth) partnered with Lee to open its first Indian Flagship store powered by Ace Turtle and will open 50 more stores in the next 12 months
• Bicycle Therapeutics (Growth & HC) announced collaboration with the German Cancer Research Center to discover and develop Bicycle® radio conjugates for a range of oncology targets and a strategic collaboration with Novartis to discover, develop and commercialize Bicycle® Radio-Conjugates
• Horizon Robotics (CN & Growth) announced that BYD's proprietary BEV (Bird's Eye View) perception solution powered by Horizon Robotics' Journey 5 will be prepared to enter mass production this year
• LaunchDarkly (US) announced New Partner Track to Expand Its Experimentation Footprint
• SemiDrive (CN) announced strategic partnership with HongJing Drive (Article in CN)
• Tulip (US) signed a Strategic Collaboration Agreement with AWS to expand capabilities driving resilience for frontline operations

• Aporia (IL) achieved HIPAA compliance to provide ML Observability to healthcare organizations
• Cymulate (IL & Growth) announced the expansion of its Attack Surface Management (ASM) solution to close gaps between traditional vulnerability management and ASM
• Desktop Metal (US) announced that its Aidro subsidiary has achieved the first-ever global AM Manufacturer certification from DNV
• Elevation Oncology (HC) highlighted clinical data for SYSA1801 (EO-3021) to be presented by partner CSPC Pharmaceutical Group Limited at ASCO 2023
• ElevateBio (HC)’s Life Edit Therapeutics announced the presentation of data demonstrating therapeutic potential of its novel gene editing platform
• LeaseLock (US) lease insurance implemented by Harbor Group Management to disrupt traditional security deposit model
• Moximed (HC) received FDA authorisation for marketing of MISHA™ Knee System for people suffering from knee osteoarthritis
• Neuspera Medical (HC) announced it received FDA clearance for the next-generation Neuspera ultra-miniaturized system
• Palleon Pharmaceuticals (HC)  announced the initial Phase 1 results from the GLIMMER-01 trial of its lead EAGLE oncology platform program, E-602
• Patsnap (SEAI & Growth) announced the launch of its first AI-Powered GPT Tool to enhance the innovation process and unveiled Synapse Visitor, the latest AI-Powered Pharmaceutical Intelligence Platform
• Semidrive (CN) announced Cheng Taiyi as its new CEO
• Taranis (US) appointed Opher Flohr as its new CEO
• Very Good Security (US) announced Chuck Yu as its new CEO

• Aruna (SEAI) received award from JP Morgan for “Top 100 Asia-Pacific Women-Powered, High-Growth Businesses”
• Evisort (US) won gold for Legal Company of the Year  in The 21st Annual American Business Awards, recognised as a 2023 Gartner® Peer Insights™ Customers' Choice for Contract Life Cycle Management (CLM)
• Geek+ (CN & Growth) bags iF Design Award for its warehouse execution system
• Gitpod (US) and Docker (US) listed in Tracxn’s Top Open Source Startups for 2023
• Growth Space (IL), Navina (IL) and Nexite (IL) recognised in CTech’s list of The 50 most promising Israeli startups for 2023
• Propseller (SEAI) listed in Tracxn’s Top Residential Real Estate Tech Startups for 2023

Vertex in the News

Here’s a recap of the notable media mentions and thought leadership articles from the Partners across our Vertex network.

VANTAGE - May'23 | Partners’ Notable Mentions

Read the full articles below:

• Ben Mathias on stricter due diligence in India
• Chua Kee Lock on his biggest investment mistake
• Zhijin Xia on opportunities in core technologies in China

Follow us on social media: